Introduction
============

Insulin-like growth factor-1 (IGF-1) is a key regulator of muscle development and metabolism in chickens. For example, IGF-1 increased cell protein content in chicken myotube ([@bib20]) and promoted chicken myoblast proliferation ([@bib39]). [@bib36] reported enhancement of growth and feed efficiency of broiler chickens receiving exogenous IGF-1. Blood IGF-1 level is elevated by refeeding ([@bib15], [@bib14]) but decreased by restriction feeding ([@bib17]) in layer chickens. Evidence shows that the plasma IGF-I profile coincided with the expression of hepatic IGF-I mRNA in broiler ([@bib4]) and layer ([@bib14]) chickens. Recently, we observed that refeeding increased the mRNA levels of IGF-1 in the liver of broiler chicks ([@bib6]). Thus, IGF-1 plays important roles as an anabolic hormone in chickens in response to feeding.

Recently, we observed that central administration of IGF-1 significantly suppressed food intake in broiler chicks ([@bib6]). However, the molecular mechanisms underlying the IGF-1-induced anorexia in chicks have not been investigated. Physiological and molecular mechanisms involved in the regulation of food intake in chickens have recently been investigated ([@bib16], [@bib22]; [@bib9]). In mammals and birds, two neuronal populations within the hypothalamus, namely, the orexigenic neuropeptide Y(NPY)/agouti-related protein (AgRP) neurons and the anorexigenic proopiomelanocortin (POMC) neurons, are believed to be critical conduits via which peripheral signals are integrated to alter the drive to eat ([@bib3]; [@bib23]; [@bib42]). [@bib13] reported that a nuclear transcription factor forkhead box O1 (FOXO1), which is directly phosphorylated by v-Akt murine thymoma viral oncogene homolog 1 (AKT), plays important roles in the transcriptional regulation of NPY, AgRP, and POMC in the mammalian hypothalamus. [@bib1] proposed that mediobasal hypothalamic p70 S6 kinase 1 (S6K1), a major downstream effector of the mechanical target of rapamycin (mTOR), controls food intake by regulating the expression of AgRP and NPY. mTOR, S6K1, and S6 proteins act downstream of AKT in mammals and chickens ([@bib35]). We recently suggested that hypothalamic AKT signaling is involved in the regulation of food intake in chicks ([@bib24]). IGF-1 promotes myoblast proliferation and skeletal muscle growth of embryonic chickens via AKT signaling ([@bib39]). All these observations prompted the hypothesis that IGF-1 suppresses food intake through the AKT signaling pathway in chicks.

[@bib31] and [@bib18] proposed that hypothalamic AMP-activated protein kinase (AMPK) regulates the transcription of hypothalamic neuropeptides in chickens. [@bib21] proposed that IGF can activate mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) under high glucose conditions in mammals. Birds maintain higher plasma glucose concentrations than other vertebrates of similar body mass (Braun and Sweazea, 2008). Therefore, it is possible that AMPK and ERK1/2 are involved in the anorexigenic action of IGF-1 in chicks.

Understanding the regulatory mechanism of feed intake in commercial chickens is important as metabolic diseases in broiler and layer chickens are serious problems in the poultry industry ([@bib12]). Several peptides or hormones show different effect on food intake between broiler and layer chicks ([@bib33]; [@bib34]; [@bib32]; [@bib30]; [@bib8]). However, the anorexigenic effect of IGF-1 in layer chicks has not yet been investigated.

In this study, we attempted to elucidate the mechanism underlying the IGF-1-induced anorexia in broiler chicks. Toward this, we investigated the effects of central administration of IGF-1 on the mRNA levels of appetite-regulating neuropeptides and signaling pathways in the hypothalamus of broiler chicks. We also compared the effect of central administration of IGF-1 on food intake in broiler and layer chicks. Our observations indicate a role of IGF-1 in the central regulation of feeding behavior in chicks.

Materials and Methods
=====================

Animals and Peptides
--------------------

This study was approved by the Institutional Animal Care and Use Committee and was performed according to the Kobe University Animal Experimentation Regulation (27-07-01). One-day-old male chicks (Ross 308) were purchased from a local hatchery (Yamamoto Co. Ltd., Kyoto, Japan for Experiments 1 and 2 and Ishii Co. Ltd., Tokushima, Japan for Experiment 3). One-day-old male layer chicks (White leghorn) were purchased from a local hatchery (Japan Layer K. K., Gifu, Japan). They were given free access to water and a commercial chick starter diet (Nichiwa Sangyo Co., Ltd., Kobe, Japan). Human IGF-1 was purchased from Novus Biologicals, LLC (Co, USA).

Experiment 1. Effect of Central Administration of IGF-1 on the mRNA Levels of Hypothalamic Neuropeptides in Chicks
------------------------------------------------------------------------------------------------------------------

Twenty-four 8-day-old chicks were weighed and allocated to two groups based on body weight. IGF-1 was dissolved in 0.85% (w/v) saline solution containing 0.1% (w/v) Evans Blue. Either 0 (control) or 300 pmol IGF-1 in a volume of 10 *µ*L was intracerebroventricularly administered according to the method of [@bib5]. At 30 min after administration, the chicks were euthanized by decapitation. The success of the injection was verified by observing the presence of Evans Blue dye in the lateral ventricle. The diencephalon was collected and preserved in RNAlater^®^ tissue storage reagent (Sigma-Aldrich Co., St. Louis, MO, USA). Total RNA extraction and cDNA synthesis were performed as described previously ([@bib10]). cDNA of *NPY* (GenBank accession no. NM_205473), *AgRP* (GenBank accession no. AB029443), and *POMC* (GenBank accession no. NM_001031098) were amplified using the following primers: NPY sense, 5′-CTT GTC GCT GCT GAT CTG -3′; NPY antisense, 5′-GCC TCA GAG CCG AGT AGT-3′; AgRP sense, 5′-G CA G G A AG GTG A TG GTAA C-3′; AgRP antisense, 5′-GTC ACA GCA GGG GAT CTG-3′; POMC sense, 5′-AGA TGG AGA AGG GTT GGA A-3′; and POMC antisense, 5′-CGT TGG GGT ACA CCT TGA-3′. cDNA of ribosomal protein S17 as an internal standard was amplified using primers as described previously ([@bib26]). mRNA levels were quantified in duplicate using PikoReal™ kit (Thermo Fisher Scentific K.K. Tokyo, Japan) and SYBR^®^ Premix Ex Taq™ II (Tli RNaseH Plus) (Takara Bio Inc., Shiga, Japan) according to the supplier\'s recommendations.

Experiment 2. Effect of Central Administration of IGF-1 on the Protein Levels of Hypothalamic Signaling Pathways in Chicks
--------------------------------------------------------------------------------------------------------------------------

Twenty-four 8-day-old chicks were weighed and allocated to two groups based on body weight, and either 0 (control) or 300 pmol IGF-1 was intracerebroventricularly administered as described above. At 30 min after administration, the chicks were euthanized by decapitation. The success of the injection was verified as described in Experiment 1. The hypothalamus was dissected, immediately frozen in liquid nitrogen, and stored at −80°C. Western blot analysis was performed as previously reported ([@bib28]). The frozen hypothalamus was ultrasonicated in a lysis buffer. Homogenates were centrifuged at 17,900×*g* for 15 min at 4°C and the supernatants were stored at −80°C. Protein concentrations were determined using Lowry\'s method. Lysates were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and western blotting using the HorizeBlot (ATTO Co., Tokyo, Japan) according to the manufacturer\'s instructions. Bands were detected using Chemi-Lumi one Super (Nacalai Tesque, Inc., Kyoto, Japan), visualized using LumiCube (Liponics Inc., Tokyo, Japan), and quantified using the CS Analyzer software (ATTO Co., Tokyo, Japan). Anti-Akt (\#9272), anti-phospho-Akt (pAkt) (Thr308) (\#9275), anti-pAkt (Ser473) (\#9271), anti-S6 ribosomal protein (S6) (\#2217), anti-phospho-S6 ribosomal protein (pS6) (Ser240/244) (\#5364), anti-FOXO1 (\#9454), anti-phospho-FOXO1 (pFOXO1) (Ser256) (\#9461), anti-*β*-actin (\#4967), anti-AMPK (\#2532), anti-phospho-AMPK (pAMPK) (Thr172) (\#2531), anti-ERK1/2 (\#4695), antiphospho-ERK1/2 (\#9101) (Thr202/Tyr204) (\#4370), anti-*α*/*β*-tubulin (\#2148) and horseradish peroxidase (HRP) - conjugated anti-rabbit IgG (\#7074) were purchased from Cell Signaling Technology (Beverly, MA, USA).

Experiment 3. Effects of Central Administration of IGF-1 on Food Intake in Broiler and Layer Chicks
---------------------------------------------------------------------------------------------------

Thirty-six 7-day-old broiler chicks or thirty-six 8-day-old layer chicks were fasted for 3 h, weighed, and allocated to four groups based on body weight. Either 0, 30, or 300 pmol IGF-1 was intracerebroventricularly administered as described above. Food intake was measured at 30, 60, and 120 min after administration. At the end of the experiment, the chicks were euthanized by decapitation. The success of the injection was verified as described in Experiment 1.

Data Analysis
-------------

Data from Experiments 1 and 2 were analyzed using Student\'s *t*-test. Data from the Experiment 3 were analyzed using the Tukey-Kramer test. All statistical analyses were performed using the commercial package (StatView version 5, SAS Institute, Cary, NC, USA, 1998).

Results and Discussion
======================

In the present study, we first examined the effect of central administration of IGF-1 on the expression of appetite regulation-related genes in chick hypothalamus and observed that IGF-1 significantly increased the mRNA levels of *POMC* ([Fig. 1](#F1){ref-type="fig"}). However, IGF-1 did not alter the mRNA levels of *NPY* and *AgRP* ([Fig. 1](#F1){ref-type="fig"}). In mammals, *POMC* expression is suppressed by unphosphorylated FOXO1, and AKT promotes cytoplasmic translocation of FOXO1 after phosphorylation ([@bib29]). Therefore, we next assessed the effect of central administration of IGF-1 on the phosphorylation of AKT signaling molecules in chick hypothalamus. IGF-1 significantly increased AKT phosphorylation, whereas the phosphorylation of FOXO1 and S6 was not induced ([Fig. 2](#F2){ref-type="fig"}). As mentioned in the Introduction, AMPK and ERK1/2 are possibly involved in the anorexigenic action of IGF-1 in chicks. Therefore, we further analyzed the phosphorylation of AMPK and ERK1/2 and observed that IGF-1 did not affect the phosphorylation of these proteins ([Fig. 3](#F3){ref-type="fig"}). These observations suggest that hypothalamic POMC and AKT may be involved in the IGF-1-induced anorexigenic pathway.

![**Effects of central administration of insulin-like growth factor-1 (IGF-1) on the mRNAlevels of appetite regulation-related genes *NPY* (a), *AgRP* (b), and *POMC* (c) in chick hypothalamus.** Data represent means±S.E.M (*n*=11). \*, Significant with respect to the control group (*p*\<0.05).](jpsa-56-270-g001){#F1}

![**Effects of central administration of insulin-like growth factor-1 (IGF-1) on the phosphorylation of AKT (Ser) (a), AKT (Thr) (b), FOXO1 (c), and S6 (d) in chick hypothalamus.** Data represent means±SEM (*n*=8). \*, Significant with respect to the control group (*p*\<0.05).](jpsa-56-270-g002){#F2}

![**Effects of central administration of insulin-like growth factor-1 (IGF-1) on the phosphorylation of AMPK (a) and ERK1/2 (b) in chick hypothalamus.** Data represent means±SEM (*n*=8).](jpsa-56-270-g003){#F3}

We also compared the effect of IGF-1 on food intake between broiler and layer chicks. Intracerebroventricular administration of IGF-1 significantly decreased food intake in both types of chicks. However, the threshold of IGF-1-induced anorexia in broiler chicks (300 pmol) was higher than that in layer chicks (30 pmol) ([Fig. 3](#F3){ref-type="fig"}). These results indicate low IGF-1 sensitivity of the hypothalamus of broiler chicks.

[@bib11] reported that broiler chicks showed higher plasma IGF-1 concentration than native chicken breeds. Fast-growing broilers had higher concentrations of IGF-1 in the serum than slow-growing broilers ([@bib38]). Thus, high concentration of plasma IGF-1 may possibly be one of the causes of fast growth of broiler chickens. In addition, the present study clearly demonstrates that the threshold of IGF-1-induced anorexia in broiler chicks was higher than that in layer chicks. Broiler chickens consume more food ([@bib40]; [@bib25]) and grow faster ([@bib41]; [@bib37]) than layer chickens. Therefore, it is possible that the high threshold of IGF-1-induced anorexia in broiler chicks is also one of the causes underlying their fast growth.

In the present study, layer chicks showed a lower threshold of central IGF-1-induced anorexia than the broiler chicks. [@bib30] reported insulin resistance in broiler chicks; central administration of insulin suppressed food intake in layer chicks, but not in broiler chicks. Therefore, differences in the sensitivity of chicks to IGF-1 and insulin may be responsible for hyperphagia in broiler chicks. We have previously shown that intracerebroventricular administration of insulin induces phosphorylation of AKT and FOXO1 in the hypothalamus of layer chicks ([@bib24]). In the present study, IGF-1 significantly induced AKT phosphorylation in the hypothalamus of chicks but did not affect FOXO1 phosphorylation. In addition, we observed the same phenomenon in insulin-administrated broiler chicks (unpublished data). Therefore, differences in the response to the hypothalamic AKT/FOXO signaling between broiler and layer chicks may be responsible for differences in the effective doses of IGF-1 and other hormones, such as insulin. Further studies are required to clarify the effect of IGF-1 on hypothalamic AKT/FOXO signaling in layer chicks.

AKT/FOXO signaling regulates food intake through the transcription of *NPY, AgRP*, and *POMC*; the unphosphorylated form of FOXO1 stimulated the transcription of *NPY* and *AgRP* but suppressed that of *POMC* in the hypothalamus of mammals ([@bib13]). In the present study, IGF-1 did not affect the phosphorylation of FOXO1, although it tended to reduce the levels of total FOXO1 (*p*=0.077, data not shown). Therefore, it is possible that IGF-1 decreases the level of unphosphorylated FOXO1, which in turn upregulates *POMC*. However, why IGF-1 did not reduce the mRNA levels of *NPY* and *AgRP* is not clear. In rats, adenovirus-mediated constitutive activation of mediobasal S6K1 decreased the mRNA levels of *NPY* and *AgRP* without affecting *POMC* mRNA levels ([@bib1]). Furthermore, IGF-1 did not induce the phosphorylation of the S6 protein, suggesting that S6K1 was not activated. Evidence shows that mTOR, an upstream activator of S6K1, can be regulated in an AKT-independent manner ([@bib29]; [@bib7]). Therefore, as the mTOR-S6K1 pathway is not activated by IGF-1, significant changes might not be detected in the mRNA levels of *NPY* and *AgRP*.

Intracerebroventricular administration of IGF-1 did not influence food intake in normal rats but significantly decreased food intake in diabetic rats ([@bib19]). Therefore, the anorexigenic effect of IGF-1 might be observed under hyperglycemic condition in rats. Birds maintain higher plasma glucose concentrations than other vertebrates of similar body mass ([@bib2]). Therefore, central administration of IGF-1 showed anorexigenic effect in chicks as well as in diabetic rats. In chickens, blood glucose ([@bib27]) and IGF-1 ([@bib14]) levels are elevated after food intake. Therefore, glucose and IGF-1 might coordinately regulate appetite as a nutritional and hormonal satiety signal in chickens.

In conclusion, we observed that intracerebroventricular administration of IGF-1 significantly increased *POMC* mRNA levels and induced AKT phosphorylation in broiler chicks. We also showed that the threshold of IGF-1-induced anorexia in broiler chicks was higher than that in layer chicks. Our observations suggest that IGF-1 may play important roles in the central regulation of feeding behavior and that the low IGF-1 sensitivity in the hypothalamus may be one of the causes of hyperphagia in broiler chicks.

![**Effects of central administration of insulin-like growth factor-1 (IGF-1) on food intake in broiler (a) and layer (b) chicks.** The number of chicks used is shown in parentheses. Groups with different letters are significantly different (*p*\<0.05).](jpsa-56-270-g004){#F4}
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